Jun 17, 2026 09:00AM
May 26, 2026 08:01AM
May 26, 2026 08:00AM
May 14, 2026 08:00AM
May 14, 2026 08:00AM
Apr 30, 2026 08:03AM
Apr 30, 2026 08:00AM Genprex Receives Patent Grant from The Israel Patent Office for the Combination of Reqorsa® Gene Therapy and PD-1 Antibodies to Treat Cancer
Apr 28, 2026 07:00AM
Apr 28, 2026 07:00AM
Apr 22, 2026 07:01AM
Apr 22, 2026 07:00AM
Apr 21, 2026 07:01AM
Apr 21, 2026 07:00AM
Apr 20, 2026 07:01AM Genprex collaborators present lung cancer gene therapy data at AACR meeting
Apr 20, 2026 07:00AM
Mar 18, 2026 07:00AM
Mar 18, 2026 07:00AM
Mar 10, 2026 07:00AM
Feb 23, 2026 08:02AM
Feb 23, 2026 08:00AM
Feb 10, 2026 08:00AM Genprex receives Australian patent approval for Reqorsa cancer therapy
Feb 10, 2026 08:00AM
Jan 7, 2026 07:00AM
Jan 6, 2026 07:01AM
Jan 6, 2026 07:00AM
Nov 24, 2025 07:00AM
Nov 24, 2025 07:00AM
Nov 19, 2025 07:00AM Genprex Adds Clinical Trial Site for Acclaim-1 and Acclaim-3 Lung Cancer Clinical Trials
Nov 18, 2025 07:00AM
Nov 18, 2025 07:00AM
Nov 4, 2025 07:02AM
Nov 4, 2025 07:00AM
Oct 28, 2025 11:20AM
Oct 28, 2025 11:19AM
Oct 28, 2025 07:00AM GENPREX collaborators present preclinical data for lung cancer therapy
Oct 28, 2025 07:00AM
Oct 23, 2025 08:12AM
Oct 23, 2025 08:12AM
Oct 23, 2025 07:02AM
Oct 23, 2025 07:00AM
Oct 14, 2025 07:00AM
Sep 2, 2025 08:30AM Genprex to Present and Participate at Upcoming September Investor and Industry Conferences
Aug 18, 2025 09:29AM
Aug 18, 2025 09:29AM
Aug 4, 2025 08:31AM
Aug 4, 2025 08:30AM
Jun 24, 2025 09:25AM
Jun 24, 2025 09:25AM
Jun 23, 2025 09:00AM Genprex Collaborators Present Research on Non-Viral Approach to Diabetes Gene Therapy Using Lipid Nanoparticle Delivery System at the 2025 American Diabetes Association 85th Scientific Sessions
Jun 3, 2025 07:00AM

323,573 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All